PARBRAZE 100

Parbraze 100mg Tablet, containing the active ingredient Olaparib, is a cancer medication classified as a PARP (poly [adenosine diphosphate-ribose] polymerase inhibitor) inhibitor. It is effectively used in the treatment of various cancers, including ovarian, breast, pancreatic, and prostate cancer, and can be administered either as a standalone therapy or in combination with other anticancer medications.

However, certain precautions are crucial when taking Parbraze 100mg Tablet. Individuals with a known allergy to Olaparib or any other components of the medicine should not take it. It is imperative to contact your doctor immediately if you experience symptoms such as breathlessness, chest pain, a rapid heart rate, fever, cough, or wheezing, as these could indicate serious side effects. Your healthcare provider will conduct regular blood tests, specifically before starting treatment and monthly thereafter, because this medication has the potential to decrease red blood cell (RBC), white blood cell (WBC), and platelet counts. Furthermore, it is important to inform your healthcare provider about any pre-existing lung, liver, heart, or kidney problems before commencing treatment.

The use of Parbraze 100mg Tablet during pregnancy is not recommended due to the potential for fetal harm and miscarriage. Therefore, women of reproductive age are advised to undergo a pregnancy test before starting this medication and should continue to use effective birth control for at least six months after the treatment concludes. Breastfeeding is also not advised during treatment as it is not known whether Parbraze 100mg Tablet passes into breast milk. Men undergoing treatment with this medication should refrain from donating sperm for at least three months after completing therapy. Finally, it is essential to inform your doctor about all medications you are currently taking, including prescription drugs, over-the-counter medicines, vitamins, and supplements, to avoid potential drug interactions.